Sesen Bio (SESN) Reports Q1 Loss of $0.35/sh

Sesen Bio (NASDAQ: SESN) reported Q1 EPS of ($0.35), versus ($0.31) reported last year. Revenue for the quarter came in at $4.31 million, versus $0 reported last year.

For earnings history and earnings-related data on Sesen Bio (SESN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c